Journey Medical (DERM) Insider Trading & Ownership → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free DERM Stock Alerts $3.57 +0.13 (+3.78%) (As of 05/8/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Journey Medical (NASDAQ:DERM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.42%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$169,300.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$9,187.50 Get DERM Insider Trade Alerts Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DERM Insider Buying and Selling by Quarter Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Journey Medical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/25/2024Lindsay A Md RosenwaldDirectorBuy10,000$3.04$30,400.00 3/22/2024Claude MaraouiCEOBuy10,000$3.48$34,800.00 3/22/2024Justin Adam SmithDirectorBuy30,000$3.47$104,100.00 2/22/2024Joseph BeneschCFOSell2,450$3.75$9,187.50 (Data available from 1/1/2013 forward) DERM Insider Trading Activity - Frequently Asked Questions Who is on Journey Medical's Insider Roster? The list of insiders at Journey Medical includes Claude Maraoui, Joseph Benesch, Justin Adam Smith, and Lindsay A Md Rosenwald. Learn more on insiders at DERM. What percentage of Journey Medical stock is owned by insiders? 19.42% of Journey Medical stock is owned by insiders. Learn more on DERM's insider holdings. Which Journey Medical insiders have been buying company stock? The following insiders have purchased DERM shares in the last 24 months: Claude Maraoui ($34,800.00), Justin Adam Smith ($104,100.00), and Lindsay A Md Rosenwald ($30,400.00). How much insider buying is happening at Journey Medical? Insiders have purchased a total of 50,000 DERM shares in the last 24 months for a total of $169,300.00 bought. Which Journey Medical insiders have been selling company stock? The following insider sold DERM shares in the last 24 months: Joseph Benesch ($9,187.50). How much insider selling is happening at Journey Medical? Insiders have sold a total of 2,450 Journey Medical shares in the last 24 months for a total of $9,187.50 sold. More Insider Trading Tools from MarketBeat Related Companies: ASMB Insider Ownership VTVT Insider Ownership LABP Insider Ownership RLYB Insider Ownership MNOV Insider Ownership SCYX Insider Ownership LFVN Insider Ownership TPST Insider Ownership MRNS Insider Ownership ANEB Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:DERM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.